Ascend Capital’s Nightstar Therapeutics NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-151,691
Closed -$2.43M – 239
2018
Q2
$2.43M Buy
151,691
+30,710
+25% +$438K 0.11% 137
2018
Q1
$1.73M Buy
+120,981
New +$1.65M 0.07% 168

Other funds holding NITE

Ascend Capital's NITE Position: Q3 2018 in Review

Ascend Capital sold out of Nightstar Therapeutics (NITE) in Q3 2018, closing a stake of 151,691 shares — an estimated $2.43M sold.

Ascend Capital first reported a position in NITE in Q1 2018 and held it in 2 quarters. The position peaked at $2.43M in Q2 2018. 36 funds tracked by Wall St. Rank hold NITE as of Q3 2018.

  • Ascend Capital reported no remaining Nightstar Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Ascend Capital sold 151,691 Nightstar Therapeutics shares in Q3 2018, an estimated $2.43M.
  • Ascend Capital first reported a position in Nightstar Therapeutics in Q1 2018 and held it in 2 quarters.
  • Ascend Capital's Nightstar Therapeutics position peaked at $2.43M in Q2 2018.
  • 36 funds tracked by Wall St. Rank held Nightstar Therapeutics as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.